Skip to content

Breaking the stigma: Psychedelic startups embrace opportunity to innovate healthcare

By Michael Joe Cini

The psychedelics sector faces scepticism due to the inclusion of substances like LSD, magic mushrooms, MDMA, ketamine, and DMT in legitimate businesses. Although breaking the stigma remains a monumental task, through diligent efforts, relatable stories, and robust scientific data and studies, the perception and opinion surrounding psychedelic treatments are gradually shifting. European psychedelics startups have … Continued

Patient-derived cancer organoids: Insights into clinical outcomes

By Michael Joe Cini

A team of researchers at the Hubrecht Institute in the Netherlands have recently developed an organoid biobank for offering insights into clinical responses that could ordinarily be elicited in patients. Organoids are derived from the tissue samples of cancer patients, and the researchers find that they mimic the tissues of the original organism in terms … Continued

Researchers at JAIST develop bacterial anti-cancer treatment

By Michael Joe Cini

Biomedical science has explored the possibility of using bacteria as an anti-cancer treatment against malignant tumours. However, previous efforts have focused on genetic modification or drug delivery to tumours, with bacteria only acting as ferries for drug-based therapy. Scientists at Japan’s Advanced Institute of Science and Technology (JAIST) in Ishikawa have now developed an anti-cancer … Continued

MIT researchers develop nanoparticle system for drug delivery

By Michael Joe Cini

A research team has recently developed a new system that uses nanoparticles to deliver toxic drugs to tumours. Known as bottlebrush particles, these immunostimulatory drugs can allow clinicians to administer medications to tumours in a controlled manner, minimizing the systemic inflammation common with immunotherapy. While in its early stages, the successful results from initial studies … Continued

Lifeblood and Med-Tech World Summit forge partnership to connect MedTech visionaries

By Michael Joe Cini

Lifeblood, a distinguished talent acquisition firm specialising in MedTech Startups, has recently forged a strategic partnership with Med-Tech World Summit The collaboration between these two entities aims to cultivate a culture of collaboration while unifying the dynamic MedTech community. By harnessing the power of this partnership, Lifeblood and Med-Tech World Summit are paving the way … Continued

NextMed brings AI-powered “Lifesaving Radio” to surgery

By Michael Joe Cini

Artificial intelligence (AI) has yet again shown its versatility as a technology being applied as a tool to greatly enhance the efficiency and capabilities of surgeons in the operating theatre. NextMed Health has been assisted by the data science from Klick Health, to successfully create the world’s first AI-based health care radio station, named “Lifesaving … Continued

Med-Tech Roadshow in London set to unite visionaries in the heart of digital health innovation

By Michael Joe Cini

Discover groundbreaking advancements and connect with industry leaders at the Med-Tech Roadshow in London The much-anticipated Med-Tech roadshow is set to take place in the vibrant city of London on Monday, May 22nd, 2023. This exciting networking event is poised to offer attendees a unique opportunity to connect with industry leaders, gain valuable insights, and … Continued

Microneedle vaccine printer scaling up outreach to people

By Michael Joe Cini

Getting vaccines to parts of the world where they’re needed in large quantities is not always easy. For efficacy, many vaccines need to be kept in cold storage during transit, and remote areas often have challenges with this infrastructure. A team of researchers has created a mobile vacuum printer that can produce hundreds of microneedle … Continued

Rapid testing breakthrough: Detecting Mpox through molecular sensors

By Michael Joe Cini

The monkeypox virus is spreading rapidly, with vaccines and current therapeutics unable to contain the spread of the virus. Public health researchers have determined that rapid testing is the best solution for mpox containment. To improve the ability of clinicians to detect the monkeypox virus, researchers at Penn State University have developed a selective molecular … Continued